Bush's precautionary principle

Commentary

Biotech companies have no choice but to fight the Bush administration's move to ban therapeutic cloning research, and only partially because the technology holds potential to provide important medical advances in the treatment of diabetes, neurological disorders such as Parkinson's disease and cardiovascular disease...